FDA & DEA Regulation of Opioid Drugs & Crisis 2022 - McDermott

FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022

Overview


Brian Malkin joins the DC Bar for their event, “FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022.” Brian and panel will cover, the regulation of opioid drugs and the legal issues involved in combating this crisis in the United States. The panel will also discuss how the US Drug Enforcement Administration (DEA) schedules opioid drugs and develops annual quotas and prevents diversion, and how pain and substance abuse treatment doctors from the American Medical Association’s perspective view these important regulatory issues and interact with the regulators at the FDA and DEA.

Learn more and register here.

Dig Deeper

Dallas, TX / McDermott Event / May 1, 2025

BIO BREAK: Dallas' Monthly Life Sciences Happy Hour

Dallas, TX / McDermott Event / April 3, 2025

Bio Break: Dallas' Monthly Life Sciences Happy Hour

Paris, France / McDermott Event / April 2, 2025

European Health & Life Sciences Symposium 2025

Saint-Étienne, France / Speaking Engagements / March 21, 2025

What Impact Will The Pharmaceutical Package Have on The French Pharmaceutical Industry?

Brussels, Belgium / Speaking Engagements / March 11, 2025

Inaugural European Summit | Women Leaders in Life Sciences Law